McKesson Corporation (MCK)

McKesson Corporation is a healthcare services company listed on the NYSE under the ticker MCK. As a common equity security, it represents ownership in the company, which serves customers in the United States and internationally. McKesson operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International.

Its U.S. Pharmaceutical business distributes branded, generic, specialty, biosimilar, and over-the-counter medicines, along with related healthcare products, while also providing practice management, technology, clinical support, and business solutions for community-based oncology and other specialty practices. The Prescription Technology Solutions segment supports biopharma and life sciences partners with services that connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Medical-Surgical Solutions supplies healthcare providers with medical and surgical products, logistics, and related services. The International segment provides medicines, supplies, information technology solutions, and distribution services across multiple healthcare settings. McKesson was founded in 1833 and is headquartered in Irving, Texas.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.